在老化中的MYBPC3载体中发生过高心肌病变
Kalyani Ananthamohan1, Julian E Stelzer2, Sakthivel Sadayappan1
1Department of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati, Cincinnati, OH 45267, USA.
概括
与MYBPC3基因突变相关的晚发性缩性心肌病 (HCM) 随着年龄的增长而恶化. 了解MYBPC3基因调节为这种遗传性心脏病提供了新的治疗途径.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 超性心肌病 (HCM) 涉及心肌厚,导致心力衰竭和突然死亡风险.
- 基因基因的突变,特别是MYBPC3,是遗传性HCM的主要原因.
- 与MYBPC3突变相关的晚发性HCM呈现出各种症状和重大健康风险.
研究的目的:
- 审查晚发性HCM的致病机制,重点关注MYBPC3基因调制.
- 评估衰老对MYBPC3水平和HCM病原发生的影响.
- 为未来的HCM治疗策略探索个性化的奥米克.
主要方法:
- 对MYBPC3基因调节在HCM的现有文献的审查.
- 分析高通量欧米克数据,识别MYBPC3变异型心肌细胞中的分子事件.
- 对MYBPC3.3的转录,后转录和后翻译修改的评估.
主要成果:
- MYBPC3突变通过诸如无意中介衰变和哈普洛缺陷等机制促进晚发性HCM.
- 老龄化加剧MYBPC3突变载体中HCM的严重程度.
- 确定了表达MYBPC3变异的心肌细胞中的分子干扰.
结论:
- 调节MYBPC3在HCM病变发生过程中至关重要,特别是在老年人中.
- 衰老显著影响MYBPC3水平和HCM进展.
- 个性化奥米克斯方法对新型晚发性HCM疗法有希望.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


